The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system

2019-07-05T10:55:33+02:00July 4th, 2019|News|

The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system Tel Aviv and Utrecht, July 8 2019 - Tel Aviv University’s (TAU) new Translational Medical Research Center has acquired a VECTor PET/SPECT/CT to help bridge the gap between academic discoveries and new products that benefit patients. The system will be [...]

UT Dallas acquires new microCT-enhanced deep-tissue Optical Imaging system.

2019-06-27T09:25:30+02:00June 19th, 2019|News|

The Department of Bioengineering at the UT Dallas is adding a MILabs Hybrid OI/CT system to its innovative medical imaging solutions. By fusing bioluminescent and fluorescent imaging with ultra-high-resolution CT, this new in-vivo imaging system enables functional treatment imaging of diseases throughout the whole-body of a small animal while providing at the same time critical [...]

MILabs Selected by Columbia University Irving Medical Center For Upgrades to its Molecular Imaging Capabilities

2019-05-07T09:27:48+02:00May 7th, 2019|News|

Utrecht, the Netherlands, February 15, 2019 The MILabs VECTor (OI/CT) system has been acquired by the Department of Radiology at Columbia University Irving Medical Center (CUIMC) to upgrade its molecular imaging capabilities. MILabs VECTor system is an extremely user-friendly, fully integrated multimodal imaging technology used for the development of new diagnostic solutions and therapies. With [...]

The Baker Heart & Diabetes Institute invests in MILabs’ in-vivo Hybrid Optical/CT tomography to support its groundbreaking platelet research

2019-04-24T15:36:14+02:00April 24th, 2019|News|

Melbourne, Australia, and Utrecht, the Netherlands, April 24 2019 - The Baker Heart and Diabetes Institute, an independent Australian-based research institute recognized internationally for its groundbreaking work on the function of platelets in heart disease and cancer, has successfully installed their Milabs hybrid U-CT/OI small animal imager. This non-invasive imaging system combines 2D and 3D [...]

MILabs installs new E-Class SPECT/CT system to enhance heart failure research at the Comprehensive Heart Failure Center (CHFC), Würzburg, Germany

2019-04-02T13:02:20+02:00April 2nd, 2019|News|

Würzburg, Germany and Utrecht, the Netherlands The nuclear cardiology core facility of the CHFC-Würzburg has acquired MILabs E-class SPECT/CT system to enhance its existing top-level basic, translational and clinical research activities in the field of heart failure. Upgradeable with simultaneous PET imaging, the E-Class SPECT/CT system combines economic use with exceptional translational imaging performance. The [...]

Barts Cancer Institute at Queen Mary University of London upgrades its imaging facility with MILabs VECTor PET/SPECT/CT

2019-07-05T10:57:42+02:00March 20th, 2019|News|

Utrecht/London March 20 2019 - Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute (BCI) has boosted its radionuclide imaging capabilities with a MILabs VECTor PET/SPECT/CT omni-tomography system. Unlike other multi-modality PET/SPECT/CT systems, the VECTor technology enables [...]

Join MILabs at our Industry Session at EMIM

2019-03-12T16:36:36+02:00March 12th, 2019|News|

Next week Thursday, during the EMIM in Glasgow, MILabs will be hosting a free Industry Session. Join us and watch the presentations of: Freek Beekman, MILabs Felix Gremse, RWTH Aachen Behdad Pouran, UMC Utrecht James Knight, Newcastle University René Raavé, Radboud UMC Nijmegen

RWTH Aachen’s ExMI Institute expands molecular imaging capabilities with MILabs’ Integrated Optical/CT system

2019-02-26T09:35:40+02:00February 25th, 2019|News|

Aachen, Germany and Utrecht, the Netherlands – February 25, 2019 MILabs B.V. is pleased to announce that the Institute of Experimental Molecular Imaging (ExMI) at the RWTH Aachen University has chosen the MILabs high resolution CT to further enhance its world-leading molecular imaging research. Together with the new MILabs optical tomography system, this unrivaled hybrid [...]

Scientist in the Spotlight: Dr. Veerle Kersemans, Imaging Core, Department of Oncology of the University of Oxford

2018-10-30T09:46:17+02:00October 8th, 2018|News|

Dr. Veerle Kersemans is the Lead Biological Scientist at the Imaging Core of the Department of Oncology at the University of Oxford. The Imaging Core is equipped with a range of preclinical imaging equipment and radiotherapy instruments and is staffed with biological and physical scientists. The synergistic capabilities of the imaging systems, including the VECTor [...]

MILabs’ VECTor6 with groundbreaking PET performance awarded Innovation of the Year at the WMIC 2018

2018-09-26T15:40:52+02:00September 18th, 2018|News|

September 15, Seattle, USA MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018. The VECTor6 system advances the state of the art of PET imaging by increasing PET resolution down to 0.55 [...]

MILabs Broadband Photon Tomography nominated for Innovation of the Year – WMIC 2018

2018-09-11T09:17:09+02:00September 10th, 2018|News|

September 4, Seattle, USA, and Utrecht, the Netherlands MILabs is pleased to announce that its new Broadband Photon Tomography technique has been nominated for the Innovation of the Year 2018 award by the World Molecular Imaging Society (WMIS) board of trustees. Broadband Photon Tomography as implemented on MILabs’ new VECTor6 platform, dramatically expands the versatility and [...]

University of Sydney acquires state-of-the-art MILabs preclinical in-vivo X-ray CT

2018-09-05T12:27:31+02:00September 3rd, 2018|News|

Sydney, Australia, and Utrecht, the Netherlands, August 31st, 2018 MILabs announces that it has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney. Recognizing that excellence in research is increasingly linked to excellence in infrastructure capability, Sydney Imaging selected MILabs X-ray CT system for [...]